Abstract
4, 6-Dinitroquinoline 1-oxide was tested for antitumor activity using Ehrlich ascites carcinoma and S-180 in ascites as well as solid type.The effect is remarkable in the case of ascites type, both for Ehrlich and S-180, showing 100% longevity in 30 days in a dose of 100γ/mouse/day (5mg./kg./day) for Ehrlich, 300γ/mouse/day (15mg./kg./day) for S-180. The chronic LD50 is 150mg./kg. for mice, and the chemotherapeutic index is 30. Toxicity for rats and dogs was also tested.A synergestic effect was found when 4, 6-dinitroquinoline 1-oxide was given together with a sub-effective dose of Mitomycin-C and INAH to the solid type of Ehrlich ascites carcinoma (Table VI and Fig. 6).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
